Skip to Main Content

Paper Details

CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivo.
Cancer Gene Ther
3
2022
Author NameAffiliation
Derya TilkiProstate Cancer Center, University Medical Center Hamburg-Eppendorf
Martina KluthInstitute of Pathology, University Medical Center Hamburg-Eppendorf
Ronald SimonInstitute of Pathology, University Medical Center Hamburg-Eppendorf
Guido SauterInstitute of Pathology, University Medical Center Hamburg-Eppendorf
Hartwig HulandProstate Cancer Center, University Medical Center Hamburg-Eppendorf
  • 1 - 5

Datasets